Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker
Anastasios I. Birmpilis, A. Paschalis, Apostolis Mourkakis, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1415-1415
Open Access | Times Cited: 54

Showing 26-50 of 54 citing articles:

Study on the Mechanism of QRICH1 Mediating PRMT1 to Regulate the Arginine Methylation Modification of cGAS to Promote Arsenics-Induced Pyroptosis in Hepatocellular Carcinoma Cells
Jiayuan Zhang, Tian Tian, Shanshan Tian, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 597-614
Open Access
NLRP3 Inflammasome-mediated pyroptosis in acute lung injury: Roles of main lung cell types and therapeutic perspectives
Jing Wang, Lulu Li, Zhen‐Ao Zhao, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114560-114560
Closed Access
Synergistic chemo-immunotherapy for osteosarcoma via a pH-responsive multi-component nanoparticle system
Dapeng Li, Yuanfan Li, Jie Cang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Broadening Horizons: Exploring mtDAMPs as a Mechanism and Potential Intervention Target in Cardiovascular Diseases
Yi Luan, Ying Luan, Yuxue Jiao, et al.
Aging and Disease (2023)
Open Access | Times Cited: 10
Efficacy and Mechanism of a Biomimetic Nanosystem Carrying Doxorubicin and an IDO Inhibitor for Treatment of Advanced Triple-Negative Breast Cancer
Chuling Hu, Yan Liu, Wei Cao, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 507-526
Open Access | Times Cited: 3
Metformin induces tumor immunogenic cell death in ovarian cancer by activating AMPK pathway
Yixiong Chen, Lufang Wang, Na Chen, et al.
Translational Oncology (2024) Vol. 47, pp. 102052-102052
Open Access | Times Cited: 3
An Overview of Hexavalent Chromium-Induced Necroptosis, Pyroptosis, and Ferroptosis
Saulesh Kurmangaliyeva, Kristina Baktikulova, Viktoriya Tkachenko, et al.
Biological Trace Element Research (2024)
Closed Access | Times Cited: 3
Nanoparticles Integrated with Mild Photothermal Therapy and Oxaliplatin for Tumor cHemotherapy and Immunotherapy
Qiong Yi, Shumin He, Kai Liao, et al.
Nanomedicine (2024) Vol. 19, Iss. 10, pp. 841-854
Closed Access | Times Cited: 2
A literature review on signaling pathways of cervical cancer cell death-apoptosis induced by Traditional Chinese Medicine
Cheng Peng, Yu Wang, Ying Guo, et al.
Journal of Ethnopharmacology (2024) Vol. 334, pp. 118491-118491
Closed Access | Times Cited: 2
Oxidative stress in pituitary neuroendocrine tumors: Affecting the tumor microenvironment and becoming a new target for pituitary neuroendocrine tumor therapy
Yuhang Zhou, Anke Zhang, Chaoyou Fang, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 10, pp. 2744-2759
Open Access | Times Cited: 6
The role of heat shock proteins in the pathogenesis of heart failure (Review)
A. P. Sklifasovskaya, М. Л. Благонравов, Anna Ryabinina, et al.
International Journal of Molecular Medicine (2023) Vol. 52, Iss. 5
Open Access | Times Cited: 5
Resolution Potential of Necrotic Cell Death Pathways
Anett Mázló, Yidan Tang, Viktória Jenei, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 16-16
Open Access | Times Cited: 8
Cucurbitacin IIa promotes the immunogenic cell death‑inducing effect of doxorubicin and modulates immune microenvironment in liver cancer
Sujuan Li, Sen Wang, Anping Zhang, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 4
Open Access | Times Cited: 1
Proteomic Analysis of Spatial Heterogeneity Identifies HMGB2 as Putative Biomarker of Tumor Progression in Adult-Type Diffuse Astrocytomas
Aline Paixão Becker, Valesio Becker, Joseph P. McElroy, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1516-1516
Open Access | Times Cited: 1
Colon Cancer Cells Treated with Lacticaseibacillus casei Undergo Apoptosis and Release DAMPs Indicative of Immunogenic Cell Death
Georgios Aindelis, Vassilis Glaros, Konstantinos Fragkoulis, et al.
Probiotics and Antimicrobial Proteins (2024)
Closed Access | Times Cited: 1
Belantamab mafodotin induces immunogenic cell death within 24 h post‐administration in newly diagnosed multiple myeloma patients
Ioannis V. Kostopoulos, Antonis Kakalis, Anastasios I. Birmpilis, et al.
American Journal of Hematology (2022) Vol. 98, Iss. 3
Open Access | Times Cited: 6
Salivary proteins offer insights into keratinocyte death during aphthous stomatitis. A case-crossover study
Camila Cofré-Leiva, Paola Andrea Camargo-Ayala, Angela Vergara-Pérez, et al.
BMC Oral Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Autocrine regulation of tumor cell repopulation by Hsp70-HMGB1 alarmin complex
Dmitry V. Sverchinsky, Bashar A. Alhasan, М. А. Микеладзе, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 3
Intratumoral administration of unconjugated Accum™ impairs the growth of pre‐established solid lymphoma tumors
Jean‐Pierre Bikorimana, Nehme El‐Hachem, Mathilde Moreau, et al.
Cancer Science (2023) Vol. 114, Iss. 12, pp. 4499-4510
Open Access | Times Cited: 2
Polymeric nano-formulation of spectrum selective RTK inhibitor strengthens anti-cancer effects via immune remodeling by endoplasmic reticulum stress-modulating mitochondrial metabolism
Li-Chan Chang, Yu‐Cheng Chin, Ping‐Ching Wu, et al.
Nano Today (2023) Vol. 54, pp. 102070-102070
Open Access | Times Cited: 2
Development and validation of prognostic index based on immunogenic cell death-related genes with melanoma
Yajun Han, Qinqin Cai, Xiaolin Xie, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Tumor growth inhibition and immune system activation following treatment with thorium-227 conjugates and PD-1 check-point inhibition in the MC-38 murine model
Axel Berg‐Larsen, Anne Mobergslien, Ingrid Moen, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 3
Immunogenic cell death (ICD) genes predict immunotherapy response and therapeutic targets in acute myeloid leukemia (AML)
Shuang Wen, Xuefeng Lv, Xiaohan Ma, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
Immunogenic cell death: A new strategy to enhancing cancer immunotherapy
Lei Dou, Yu Fang, Huiyuan Yang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Construction of a non-negative matrix factorization model of immunogenic cell death-related genes in lung adenocarcinoma and analysis of survival prognosis
Si‐Yang Maggie Liu, De-jing Huang, En-yu Tang, et al.
Heliyon (2023) Vol. 9, Iss. 4, pp. e14820-e14820
Open Access | Times Cited: 1

Scroll to top